Home › Funds › Yiheng Capital Management, L.P. › KYMR
Yiheng Capital Management, L.P. position in KYMR
KYMERA THERAPEUTICS INC · Health Care
Yiheng Capital Management, L.P. reported holding 63,440 shares of KYMR (KYMERA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$7.1M, representing 2.75% of its reported portfolio and ranking #13 among its reported holdings. Yiheng Capital Management, L.P. has disclosed KYMR holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Yiheng Capital Management, L.P.'s KYMR position evolved
Yiheng Capital Management, L.P. first disclosed a stake in KYMR in Q1 2025 at 122,605 shares (US$3.4M). The position peaked in Q2 2026 at 63,440 shares, worth US$7.3M. Across 7 filings, Yiheng Capital Management, L.P. increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 63,440 shares valued at US$7.1M. Notable position changes include a 40% trim in Q4 2025 (shares rose 7% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 122.61K | $3.36M | New |
| Q2 2025 | 122.61K | $5.35M | Hold |
| Q3 2025 | 122.61K | $6.94M | Hold |
| Q4 2025 | 73.44K | $5.71M | Reduce |
| Q1 2026 | 73.44K | $6.12M | Hold |
| Q2 2026 | 63.44K | $7.27M | Reduce |
| Q3 2026 | 63.44K | $7.09M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About KYMR and 13F data
KYMR (KYMERA THERAPEUTICS INC) is a Health Care company. 54 other funds we track also report a position in KYMR — the largest reported positions include BAKER BROS. ADVISORS LP (US$992.7M), Avoro Capital Advisors LLC (US$835.6M), T. Rowe Price Investment Management, Inc. (US$717.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding KYMR
- BAKER BROS. ADVISORS LP 8.66M sh · $992.73M · Q2 2026
- Avoro Capital Advisors LLC 7.47M sh · $835.60M · Q3 2026
- T. Rowe Price Investment Management, Inc. 6.26M sh · $717.52M · Q2 2026
- BVF INC/IL 3.87M sh · $444.01M · Q2 2026
- Atlas Venture Life Science Advisors, LLC 2.85M sh · $318.33M · Q3 2026
- Siren, L.L.C. 2.78M sh · $311.32M · Q3 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 808.10K sh · $90.34M · Q3 2026
- Merck & Co., Inc. 772.16K sh · $86.32M · Q3 2026
- FRONTIER CAPITAL MANAGEMENT CO LLC 740.87K sh · $84.96M · Q2 2026
- EVENTIDE ASSET MANAGEMENT, LLC 490.61K sh · $54.84M · Q3 2026
- Boxer Capital Management, LLC 429.10K sh · $49.20M · Q2 2026
- Rock Springs Capital Management LP 409.63K sh · $45.79M · Q3 2026
More on Yiheng Capital Management, L.P.
FAQ
How long has Yiheng Capital Management, L.P. held KYMR?
Yiheng Capital Management, L.P. has disclosed KYMR holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
What is Yiheng Capital Management, L.P.'s current position in KYMR?
As of Q3 2026, Yiheng Capital Management, L.P. holds 63.44K shares of KYMR (KYMERA THERAPEUTICS INC), valued at $7.09M, representing 2.75% of its reported portfolio and ranking #13.
Has Yiheng Capital Management, L.P. been buying or selling KYMR?
In the latest 13F filing (Q3 2026), Yiheng Capital Management, L.P. held unchanged its position in KYMR. The position peaked in Q2 2026 at 63.44K shares.
Which other funds hold KYMR?
Other major institutional holders of KYMR include BAKER BROS. ADVISORS LP, Avoro Capital Advisors LLC, T. Rowe Price Investment Management, Inc., among 54 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.